Hercules Capital Provides $200MM Term Loan to Phantom Pharmaceuticals
Phathom Pharmaceuticals, a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, obtained a $200 million term loan facility from Hercules Capital.
September 21, 2021
Armentum Partners | Bryan Jadot | Hercules Capital | Lake McGuire | Phathom Pharmaceuticals | Terrie Curran
Ian Koplin